SCN1A and Cognitive impairment: Similarly, increased anxiogenic-like behaviors and cognitive impairments were detected in the Scn1a +/− mouse model of Dravet syndrome [66], as well as in chemical models of limbic seizures induced by chronic and sub-chronic pentylenetetrazole (PTZ) administration [67,68].